Antithrombotic Strategies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|24|4|496-510

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.24, Iss.4, 2018-04, pp. : 496-510

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selection of Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention

By  

Current Pharmaceutical Design, Vol. 22, Iss. 29, 2016-09 ,pp. : 4604-4609

Bentham Science Publishers

Access to resources Recommend Favorite

Management of antithrombotic therapy for acute coronary syndromes and atrial fibrillation in patients with hemophilia

By Mannucci Pier Mannuccio  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 505-510

Informa Healthcare

Access to resources Recommend Favorite

Bivalirudin: A Review of its Use in Patients Undergoing Percutaneous Coronary Intervention

By Moen Marit D.   Keating Gillian M.   Wellington Keri  

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1869-1891

Adis International

Access to resources Recommend Favorite

Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention

By Hamdalla Hussam   Moliterno David J  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1669-1673

Informa Healthcare

Access to resources Recommend Favorite

Anemia in Patients Undergoing Percutaneous Coronary Intervention: Current Issues and Future Directions

By Wang Tracy Y.   Rao Sunil V.  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 4, 2007-01 ,pp. : 225-233

Adis International

Access to resources Recommend Favorite